Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "vrsta gradiva" (1) AND "polno besedilo" AND "organizacija" (Onkološki inštitut Ljubljana) .

231 - 240 / 3945
Na začetekNa prejšnjo stran20212223242526272829Na naslednjo stranNa konec
231.
Digital ischemic events related to gemcitabine : report of two cases and a systematic review
Cvetka Grašič-Kuhar, Tanja Mesti, Branko Zakotnik, 2010, izvirni znanstveni članek

Objavljeno v DiRROS: 15.03.2024; Ogledov: 102; Prenosov: 36
.pdf Celotno besedilo (621,57 KB)

232.
Radiotherapy in combination with vascular-targeted therapies
Eva Ćirić, Gregor Serša, 2010, pregledni znanstveni članek

Objavljeno v DiRROS: 15.03.2024; Ogledov: 101; Prenosov: 30
.pdf Celotno besedilo (1,06 MB)

233.
234.
Role of radiotherapy in melanoma management
Primož Strojan, 2010, pregledni znanstveni članek

Objavljeno v DiRROS: 14.03.2024; Ogledov: 104; Prenosov: 29
.pdf Celotno besedilo (928,27 KB)

235.
236.
237.
Presence and role of Simian Virus 40 (SV40) in malignant pleural mesothelioma
Julija Hmeljak, Andrej Cör, 2009, pregledni znanstveni članek

Ključne besede: viral carcinogenesis, simian virus 40, mesothelioma, T antigen
Objavljeno v DiRROS: 08.03.2024; Ogledov: 96; Prenosov: 34
.pdf Celotno besedilo (427,91 KB)

238.
Postoperative radiochemotherapy for gastric adenocarcinoma : long term results
Irena Oblak, Franc Anderluh, Vaneja Velenik, 2009, izvirni znanstveni članek

Povzetek: Background. To analyze the efficacy of postoperative radiochemotherapy with 5-florouracil (5-FU) and leucovorin (LV) applied in the patients with gastric carcinoma treated in a single institution. Patients and methods. Between 2001 and 2004, 123 patients with resected gastric adenocarcinoma were treated with postoperative concomitant radiochemotherapy with 5-FU and LV. The adjuvant treatment consisted of five cycles of chemotherapy with 5-FU (425mg/m2 IV) andLV (20 mg/m2 IV) and concomitant radiotherapy with the total dose of 45 Gy.Results. The treatment was completed according to the protocol in 82% of patients. The frequency and severity of early toxic effects induced by radiochemotherapy were manageable. Median follow-up time of 56 survivors was 64.5 months (range: 51.7-96.4 months). The 5-year locoregional control (LRC), diseasefree survival (DFS), disease-specific survival (DSS) and overall survival (OS) were 81%, 48.3%, 50.4%, and 48.4%, respectively. The multivariate analysis showed that the tumor involvement of cardia and low intensity of chemotherapy were independent adverse prognostic factors for DSS and OS. More advanced pT-stage and tumors with diffuse growth type according to Lauren were identified as negative independent prognostic factor for OS. They were also on the threshold of statistical significance for DSS. Conclusions. Postoperative radiochemotherapy for gastric carcinoma has acceptable toxicity, and is effective particularly in regard to LRC. High incidence of distant metastases calls for more effective systemic regimens.
Objavljeno v DiRROS: 08.03.2024; Ogledov: 89; Prenosov: 28
.pdf Celotno besedilo (94,49 KB)

239.
Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression
Tadej Dovšak, Alojz Ihan, Vojislav Didanovič, Andrej Kansky, Nataša Ihan Hren, 2009, izvirni znanstveni članek

Povzetek: Background. The aim of our study was to evaluate the influence of the surgery and radiotherapy of the advanced oral squamous cell carcinoma on the complete blood count, body mass index (BMI), acute inflam-matory response, liver enzymes and expression of the CD64 index on leukocytes in the peripheral blood. Patients and method. Venous blood was obtained from 16 patients with advanced oral squamous cell carcinomas treated with radical surgery and external beam radiotherapy. Blood samples were collected prior to surgery (T1), after surgery (T2) and after radiotherapy (T3). Blood samples were analyzed for whole blood count, immunoglobulin G levels, liver enzymes (transaminases (ALT and AST) and gammaglutamyl trasferase (?-GT)), inflammatory response markers (C-reactive protein, erythrocyte sedimentation rate, albumin, white blood count, leukocyte count and CD64 expression on leukocytes). Assessment of nutrition was done by calculating the body mass index.Results. Surgery caused anaemia, trombocytosis, leukocytosis, lymphopenia, rise in acute phase proteins, elevation of CD64 expression on monocytes and neutrophyls, elevation of liver transaminases and lowering of ?-GT, albumin, protein and bilirubin levels. After radiotherapy haemoglobin, leukocytes, C-reactive protein, erythrocyte sedimentation rate, liver transferases, albumin, bilirubin and proteins returned almost to T1 levels, levels of lymphocytes, ?-GT and body mass index lowered. IgG levels remained almost unchanged at T2 and T3. Levels of the CD64 expression on monocytes and neutrophyls also elevated after radiotherapy.Conclusions. Surgery caused a significantly larger acute phase response than radiotherapy, while radiotherapy worsened the already present lymphopenia.
Objavljeno v DiRROS: 08.03.2024; Ogledov: 121; Prenosov: 33
.pdf Celotno besedilo (117,17 KB)

240.
Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy
Borut Kragelj, 2009, izvirni znanstveni članek

Povzetek: Background. Radiotherapy aimed at prostatic bed (PBRT) can prevent recurrence or reestablish remission in prostate cancer patients primarily treated with prostatectomy. In selected patients results may be improved with the additional irradiation of pelvic nodes (WPRT). Patients and methods. The objective of the study was to evaluate late toxicity of postoperative radiotherapy in 43 patients - 21/43 treated with WPRT. Dysuria, haematuria, nocturia, continence and obstructive urination problems as well as urgency, continence, frequency, pain and bleeding of defecations were prospectively registered and converted to a modified Radiation Therapy Oncology Group (RTOG)- late effects normal tissue (LENT) scoring system. Median tumour dose (TD) for PBRT was 64.8 (59.4-70.0) Gy and for WPRT 50.4 (48.0-56.0) Gy. Results. More important than the deterioration of intestinal function (worsening for 1 grade in 54% and >= 2 grades in 5% of patients) was the deterioration of urinary function (worsening for 1 grade in 33% and >= 2 grades in 26% of patients). This appeared to be more frequent in patients withWPRT than PBRT (67% vs. 50% of patients) especially in conjunction with WPRT TD > 52 Gy (deterioration in 71% of patients). Conclusions. Although several factors may influence increased urinary toxicity after WPRT, it seems reasonable to lower the urinary bladder dose as it possible with novel radiation techniques.
Objavljeno v DiRROS: 08.03.2024; Ogledov: 114; Prenosov: 25
.pdf Celotno besedilo (83,78 KB)

Iskanje izvedeno v 0.85 sek.
Na vrh